UGCG and B-cell chronic lymphocytic leukemia: UGCG catalyzes the conversion of pro-apoptotic ceramide to anti-apoptotic glucosylceramide, which mediates chemotherapy resistance in chronic lymphocytic leukemia (CLL) (Schwamb et al., 2012).